Sue Behrens is a biologics and vaccine manufacturing expert with 30+ years of experience in cGMP manufacturing environments. Her global experience encompasses all aspects of scale-up and production of biopharmaceutical products and provides manufacturing consulting services for bulk drug substance and aseptic filling of drug products. She also provides due diligence for novel technologies and business opportunities for clients as well as CMC regulatory support for EMA/FDA submissions. She previously served as the Senior Director for Process Engineering at Integrated Project Solutions (IPS) in Blue Bell, PA. Within that role, she developed innovative and cost-effective solutions for complex research and manufacturing facilities within the life sciences industry.

Prior to consulting, Behrens held progressive leadership positions with Merck & Co., Inc. for 20 years. Starting her career supporting large-scale fermentation operations, she held positions of increasing responsibility in research and development, as well as capital team leadership. She oversaw sterile process technology and engineering functions at Merck’s largest site, including the launch of four new products. Ultimately, Behrens provided biologics manufacturing technology leadership at multiple development and manufacturing sites worldwide. She maintains affiliations with the International Society of Pharmaceutical Engineers, Women in Bio, and BioProcess International organizations.

EDUCATION

University of California, Berkeley
PhD, Chemical Engineering

University of Michigan
BSE, Chemical Engineering